Loading...
PRAME expression and promoter hypomethylation in epithelial ovarian cancer
PRAME is a cancer-testis antigen (CTA) and potential immuno-therapeutic target, but has not been well-studied in epithelial ovarian cancer (EOC) or its high grade serous (HGSC) subtype. Compared to normal ovary, PRAME expression was significantly increased most EOC, regardless of stage and grade. In...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5216727/ https://ncbi.nlm.nih.gov/pubmed/27322684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9977 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|